Iain Mattaj and Giuseppe Testa among the signatories of an anti-COVID19 proposal
Milan, 26 March – Director Iain Mattaj and Giuseppe Testa, Head of Neurogenomics Centre signed a letter to the Prime Minister, Giuseppe Conte, and the Governors of the Regions for a Covid19 National Anti-Counting Action Plan.
The appeal was promoted by Ruggero De Maria, Catholic University of the Sacred Heart, Rome; Andrea Grazian and Emilio Hirsch, University of Turin; Gioacchino Natoli and Pier Giuseppe Pelicci, European Institute of Oncology, IRCCS, Milan; Giorgio Stassi, University of Palermo and Paolo Vineis, Imperial College, London and was signed by over 290 representatives of the scientific community.
A networked system of laboratories spread throughout the country and based on the expertise available in research centres could help to stop the acceleration of the pandemia. In fact, according to the signatories “the current containment strategies based on the identification of symptomatic subjects alone are not sufficient to rapidly reduce the spread of the contagion“.
Read the Sole 24 ore article here: https://www.ilsole24ore.com/art/coronavirus-290-scienziati-italiani-chiedono-piu-test-laboratori-ricerca-pronti-ADfcEfF?fbclid
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.